Zobrazeno 1 - 10
of 327
pro vyhledávání: '"Oni-Orisan A"'
Autor:
Peixiang Zhang, Joseph J. Munier, Carrie B. Wiese, Laurent Vergnes, Jenny C. Link, Fahim Abbasi, Emilio Ronquillo, Katherine Scheker, Antonio Muñoz, Yu-Lin Kuang, Elizabeth Theusch, Meng Lu, Gabriela Sanchez, Akinyemi Oni-Orisan, Carlos Iribarren, Michael J. McPhaul, Daniel K. Nomura, Joshua W. Knowles, Ronald M. Krauss, Marisa W. Medina, Karen Reue
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Statin drugs lower blood cholesterol levels for cardiovascular disease prevention. Women are more likely than men to experience adverse statin effects, particularly new-onset diabetes (NOD) and muscle weakness. Here we find that impaired glu
Externí odkaz:
https://doaj.org/article/332ede39ee3b4894add02807a1a4ed96
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tanushree Haldar, Akinyemi Oni-Orisan, Thomas J. Hoffmann, Catherine Schaefer, Carlos Iribarren, Ronald M. Krauss, Marisa W. Medina, Neil Risch
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-11 (2022)
Abstract Background Prior studies of the glycemic effect of statins have been inconsistent. Also, most studies have only considered a short duration of statin use; the effect of long-term statin use on fasting glucose (FG) has not been well examined.
Externí odkaz:
https://doaj.org/article/4620badd8b7f483582fef8c858bcb07f
Autor:
Adeola Oni-Orisan
Publikováno v:
Global Public Health, Vol 18, Iss 1 (2023)
ABSTRACTThe high risk of maternal death in Africa has cast a shadow over representations and experiences of pregnancy and childbirth. In the 1980s, amid new awareness of disparities in maternal mortality rates between high and low-income countries, t
Externí odkaz:
https://doaj.org/article/232dde6d43db498c9d172744a933f3e1
Autor:
Akinyemi Oni‐Orisan, Nithya Srinivas, Krina Mehta, Jesmin Lohy Das, Thu T. Nguyen, Geoffrey H. Tison, Scott R. Bauer, Maria Burian, Ryan S. Funk, Richard A. Graham, Biomarkers and Translational Tools Community Working Group of the American Society for Clinical Pharmacology and Therapeutics
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 784-790 (2021)
Abstract Although traditional approaches to biomarker discovery have elucidated key molecular markers that have improved drug selection (precision medicine), the discovery of biomarkers that inform optimal dose selection (precision dosing) continues
Externí odkaz:
https://doaj.org/article/a38a3cf9a98f4d94ab512a4c680c3614
Autor:
Oni-Orisan, Adeola1 adeola.oni-orisan@ucsf.edu
Publikováno v:
Global Public Health. Jan2023, Vol. 18 Issue 1, p1-13. 13p.
Autor:
Neha Mantri, Meng Lu, Jonathan G. Zaroff, Neil Risch, Thomas Hoffmann, Akinyemi Oni‐Orisan, Catherine Lee, Carlos Iribarren
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 27, Iss 1, Pp n/a-n/a (2022)
Abstract Background TdP is a form of polymorphic ventricular tachycardia which develops in the setting of a prolonged QT interval. There are limited data describing risk factors, treatment, and outcomes of this potentially fatal arrhythmia. Objective
Externí odkaz:
https://doaj.org/article/1c61a7d68c664623a160ec22860fc057
Autor:
Elizabeth Y Wang, Benjamin N Breyer, Austin W Lee, Natalie Rios, Akinyemi Oni-Orisan, Michael A Steinman, Ida Sim, Stacey A Kenfield, Scott R Bauer
Publikováno v:
JMIR Human Factors, Vol 8, Iss 4, p e30767 (2021)
BackgroundMobile health (mHealth) apps may provide an efficient way for patients with lower urinary tract symptoms (LUTS) to log and communicate symptoms and medication side effects with their clinicians. ObjectiveThe aim of this study was to explor
Externí odkaz:
https://doaj.org/article/36a8d6a871224a01a55a8f95fc728bf8
Autor:
Austin W Lee, Stacey A Kenfield, Elizabeth Y Wang, Anthony Enriquez, Akinyemi Oni-Orisan, Michael A Steinman, Ida Sim, Benjamin N Breyer, Scott R Bauer
Publikováno v:
JMIR Formative Research, Vol 5, Iss 12, p e30762 (2021)
BackgroundContinuous α1a-blockade is the first-line treatment for lower urinary tract symptoms (LUTS) among older men with suspected benign prostatic hyperplasia. Variable efficacy and safety for individual men necessitate a more personalized, data-
Externí odkaz:
https://doaj.org/article/f82a1ceb71c44a72bd6a6fca38f79a65
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.